Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 176.25MEnterprise Value
VS
Market
Sector
Industry
History
$ 5.78Close
$ 2.41 - $ 6.65 52-Week Range
Ticker Information
Ticker
EPRXCompany Name
EUPRAXIA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQEUPRAXIA PHARMACEUTICALS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EPRX - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 19.77M | $ 35.06K | $ 176.25M | $ 195.98M |
| 3/31/2025 | $ 27.45M | $ 52.77K | $ 118.15M | $ 145.55M |
| 12/31/2024 | $ 33.1M | $ 71.86K | $ 106.33M | $ 139.36M |
| 9/30/2024 | $ 8.66M | $ 93.05K | $ 104.11M | $ 112.67M |
| 6/30/2024 | $ 23.32M | $ 4.66M | $ 66.48M | $ 85.14M |
| 3/31/2024 | $ 35.91M | $ 9.56M | $ 76.96M | $ 103.31M |
| 12/31/2023 | $ 19.34M | $ 10.45M | $ 0 | $ 0 |
| 9/30/2023 | $ 33.21M | $ 15.41M | $ 0 | $ 0 |
Key Performance Insights, Last 5 Years
- EUPRAXIA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV stands at $ 0.
- Over the past 5 years, EUPRAXIA PHARMACEUTICALS INC's average EV has been $ 108.04M.
- The median EV for EUPRAXIA PHARMACEUTICALS INC during this period was $ 105.22M
- EUPRAXIA PHARMACEUTICALS INC reached its highest EV over the past 5 years at $ 176.25M.
- The lowest EV recorded by EUPRAXIA PHARMACEUTICALS INC in the same timeframe $ 66.48M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for EUPRAXIA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 15.41M ] - CashnEq [ $ 33.21M ]
(=) EV [ $ 0 ] EPRX - Enterprise Value, Last 5 years
$ 66.48M
Minimum
Jun 30, 2024
$ 176.25M
Maximum
Jun 30, 2025
$ 108.04M
Average
$ 105.22M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.66B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.33K |
|---|---|
| min | $ -1.69B |
| max | $ 6.81B |
| average | $ 1.25B |
| median | $ 438.06M |
| std | $ 1.66B |